Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson...
FDA Recall #D-0630-2021 — Class III — May 26, 2021
Product Description
Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10
Reason for Recall
Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam
Recalling Firm
McKesson Corporation dba McKesson Drug Company — Memphis, TN
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
210 cartons
Distribution
Nationwide in the US
Code Information
Lot: 0000124916 Exp. 09/30/2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.